Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Morris

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancerPatrick G Morris, Colleen Lynch, John N Feeney, et al.
Irish Journal of Medical Science|June 28, 2018
Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapyMark K Doherty, Emer O'Connor, David Hannon, et al.
Oncogene|February 12, 2020
Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancerSean P Kennedy, Michael O'Neill, Darren Cunningham, et al.
Medicine|January 10, 2018
The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapyEnda J Hannan, Donal P O'Leary, Stephen P MacNally, et al.
Nature Medicine|June 28, 2011
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungsThordur Oskarsson, Swarnali Acharyya, Xiang H-F Zhang, et al.
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastasesPatrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2013
Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancerPatrick G Morris, Xi Kathy Zhou, Ginger L Milne, et al.
Irish Journal of Medical Science|January 15, 2021
Chemotherapy in the Covid-19 era: the patient's perceptionMaeve A Hennessy, Anna Linehan, Darren Cowzer, et al.
Journal of Personalized Medicine|August 27, 2021
Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon AdenocarcinomaRobert J Smyth, Valentina Thomas, Joanna Fay, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancerPatrick G Morris, Colleen Lynch, John N Feeney, et al.
Irish Journal of Medical Science|June 28, 2018
Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapyMark K Doherty, Emer O'Connor, David Hannon, et al.
Oncogene|February 12, 2020
Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancerSean P Kennedy, Michael O'Neill, Darren Cunningham, et al.
Medicine|January 10, 2018
The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapyEnda J Hannan, Donal P O'Leary, Stephen P MacNally, et al.
Nature Medicine|June 28, 2011
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungsThordur Oskarsson, Swarnali Acharyya, Xiang H-F Zhang, et al.
The Breast Journal|May 22, 2012
Limited overall survival in patients with brain metastases from triple negative breast cancerPatrick G Morris, Conleth G Murphy, Divya Mallam, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 15, 2012
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastasesPatrick G Morris, Maurizio Fazio, Azeez Farooki, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2013
Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancerPatrick G Morris, Xi Kathy Zhou, Ginger L Milne, et al.
Irish Journal of Medical Science|January 15, 2021
Chemotherapy in the Covid-19 era: the patient's perceptionMaeve A Hennessy, Anna Linehan, Darren Cowzer, et al.
Journal of Personalized Medicine|August 27, 2021
Tumour Genome Characterization of a Rare Case of Pulmonary Enteric Adenocarcinoma and Prior Colon AdenocarcinomaRobert J Smyth, Valentina Thomas, Joanna Fay, et al.
Pageof 10